Advertisement
AORT vs ISRG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and ISRG is a Hold.
AORT's RSI Indicator recovers from oversold territory
The RSI Oscillator for AORT moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In 18 of the 20 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on AORT as a result. In 62 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for AORT just turned positive on October 14, 2026. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in 220 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 62 cases where AORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
AORT broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AORT entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.594) is normal, around the industry mean (4.170). AORT's P/E Ratio (-474.200) is considerably lower than the industry average of (1.500). Projected Growth (PEG Ratio) (4.200) is also within normal values, averaging (11.253). Dividend Yield (0.005) settles around the average of (0.010) among similar stocks. P/S Ratio (2.603) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. AORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ISRG sees MACD Histogram just turned negative
ISRG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 31 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 72%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ISRG moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 16 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where ISRG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ISRG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
ISRG broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on ISRG as a result. In 50 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
Following a +2.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ISRG advanced for three days, in 211 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 183 of 264 cases where ISRG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. ISRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ISRG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.374) is normal, around the industry mean (4.946). P/E Ratio (54.536) is within average values for comparable stocks, (38.797). Projected Growth (PEG Ratio) (1.931) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (12.469) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
AORT | ISRG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 95 | 73 | |
SMR RATING 1..100 | 91 | 51 | |
PRICE GROWTH RATING 1..100 | 62 | 45 | |
P/E GROWTH RATING 1..100 | 99 | 81 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AORT's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for ISRG (79). This means that AORT’s stock grew significantly faster than ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (73) in the Medical Specialties industry is in the same range as AORT (95). This means that ISRG’s stock grew similarly to AORT’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is somewhat better than the same rating for AORT (91). This means that ISRG’s stock grew somewhat faster than AORT’s over the last 12 months.
ISRG's Price Growth Rating (45) in the Medical Specialties industry is in the same range as AORT (62). This means that ISRG’s stock grew similarly to AORT’s over the last 12 months.
ISRG's P/E Growth Rating (81) in the Medical Specialties industry is in the same range as AORT (99). This means that ISRG’s stock grew similarly to AORT’s over the last 12 months.
| AORT | ISRG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 43% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 75% | 2 days ago 66% |
| Advances ODDS (%) | 2 days ago 73% | 2 days ago 67% |
| Declines ODDS (%) | 8 days ago 67% | 8 days ago 61% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 69% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AORT’s FA Score shows that 1 FA rating(s) are green while ISRG’s FA Score has 0 green FA rating(s).
- AORT’s FA Score: 1 green, 4 red.
- ISRG’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AORT’s TA Score shows that 4 TA indicator(s) are bullish while ISRG’s TA Score has 3 bullish TA indicator(s).
- AORT’s TA Score: 4 bullish, 4 bearish.
- ISRG’s TA Score: 3 bullish, 5 bearish.
Price Growth
AORT (@Medical/Nursing Services) experienced а +3.36% price change this week, while ISRG (@Pharmaceuticals: Other) price change was -1.15% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.37%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.02%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.45%. For the same industry, the average monthly price growth was +1.98%, and the average quarterly price growth was +15.93%.
Reported Earning Dates
AORT is expected to report earnings on Nov 05, 2026.
ISRG is expected to report earnings on Jan 26, 2027.
Industries' Descriptions
@Medical/Nursing Services (+2.37% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+3.45% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
AORT and
Correlation & Price change
A.I.dvisor indicates that over the last year, AORT has been loosely correlated with VREX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then VREX could also see price increases.
| Ticker / NAME | Correlation To AORT | 1D Price Change % | ||
|---|---|---|---|---|
| AORT | 100% | +0.55% | ||
| VREX - AORT | 55% Loosely correlated | +0.38% | ||
| TCMD - AORT | 43% Loosely correlated | +8.35% | ||
| LMAT - AORT | 42% Loosely correlated | -0.81% | ||
| ISRG - AORT | 39% Loosely correlated | +0.89% | ||
| UTMD - AORT | 39% Loosely correlated | -0.75% | ||
More | ||||
ISRG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
|---|---|---|---|---|
| ISRG | 100% | +0.89% | ||
| BSX - ISRG | 73% Closely correlated | -1.85% | ||
| SYK - ISRG | 64% Loosely correlated | +1.22% | ||
| NTRA - ISRG | 54% Loosely correlated | +2.56% | ||
| GKOS - ISRG | 51% Loosely correlated | -2.33% | ||
| PODD - ISRG | 49% Loosely correlated | +0.81% | ||
More | ||||